Vanda Pinto, PhD, science writer —

​​Vanda is a biochemist with a PhD in biomedicine from the University of Porto, Portugal. She conducted her postdoctoral research first at the Bristol Medical School, U.K., studying the insulin-PI3K/Akt signaling pathway in diabetic nephropathy, then at the Institute of Molecular Pathology and Immunology of the University of Porto, where her focus was on glycosylation in lupus nephritis and inflammatory bowel disease. She next made the switch to science publishing, handling papers in biochemistry, molecular biology, and immunology.

Articles by Vanda Pinto

2 Tumor Surgeries Lead to Similar Results, Different Recovery Times

Removing a pituitary tumor through the nostrils with an endoscope led to shorter recovery times for patients with Cushing’s disease than for those who had the surgery through the traditional microscopic approach, a study reports. However, similar remission, recurrence, and complication rates were found between patients, regardless of the…

Single-incision Subxiphoid Surgery Used for Ectopic Tumor

A minimally invasive chest surgery using a single-incision subxiphoid approach was used to effectively remove a tumor in the thymus of a 29-year-old woman with ectopic Cushing’s syndrome, as described in a recent case report. The muscle-sparing incision causes less trauma and potentially could reduce post-surgical pain and shorten recovery…

Bilateral Adrenalectomy Riskier Than Unilateral, Study Says

A bilateral adrenalectomy — a surgery to remove both adrenal glands — to lower cortisol levels in patients with Cushing’s syndrome was associated with more severe post-surgery complications and a higher mortality rate, compared with unilateral adrenalectomy, a study has found. “If indicated, bilateral adrenalectomy is a feasible option for…

High Blood Sugar Levels Reduced in Most Cushing’s Procedures

Hyperglycemia, or high concentrations of sugar in the blood, can be brought to normal levels, or considerably reduced, in almost 70% of people with both Cushing’s syndrome and hyperglycemia following curative surgery or radiation therapy, a study has found. The report highlighted the need for close monitoring and adjusting medications…

Xeris’ Recorlev Now Available in US From PANTHERx Rare Pharmacy

Xeris Biopharma’s newly approved therapy Recorlev (levoketoconazole) is now available to patients in the U.S. through the specialty pharmacy PANTHERx Rare, the company announced in a press release. The therapy is prescribed for adults with endogenous Cushing’s syndrome for whom surgery is not possible or not effective. “The commercial…

Rare Chest Tumor Causes Cushing’s Syndrome in Chinese Man

A mediastinal paraganglioma, an extremely rare tumor located between the lungs, was found to be the cause of Cushing’s syndrome in a 40-year-old Chinese policeman, according to a recent case report. Doctors were particularly challenged by this case because the patient also had a pituitary tumor, which could have been…

Imaging Tests Mislead Physicians in Diagnosing Cushing’s Patient

Blood tests should be performed before imaging examinations when Cushing’s syndrome is suspected, to prevent misdiagnosis, a recent case report study suggests. The report described the case of a 24-year-old woman with elevated cortisol levels and a pituitary tumor, in which an imaging test misled doctors into believing she had…